Trial Profile
Phase I trial of DCVax lung cancer vaccine in patients with non-small cell lung cancer.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Sep 2006
Price :
$35
*
At a glance
- Drugs Dendritic cell vaccine-Northwest Biotherapeutics (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 14 Sep 2006 Status change
- 14 Sep 2006 New trial record.